2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow regdanvimab: new trials by email Literature Review of regdanvimab trials Research Report on regdanvimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19) CT-P59 - SARS-CoV-2 Infection | Phase 1 | Completed | Celltrion | 18 | 2020-09-04 | 2022-04-08 |
| To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy Subjects CT-P59, Placebo - SARS-CoV-2 Infection | Phase 1 | Completed | Celltrion | 32 | 2020-07-18 | 2021-11-16 |
COVID-19 (2)
Celltrion (2)
South Korea (2)